The End of the "Self-Affirmed" Era: Trump Administration Proposes Landmark Shakeup of US Food Safety Regulations

In a move that signals a seismic shift in American food governance, the Trump administration has officially published a long-awaited proposal to overhaul the "Generally Recognized as Safe" (GRAS) regulatory framework. Spearheaded by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., the initiative aims to dismantle the long-standing system that allows food companies to unilaterally determine the safety of their own ingredients, effectively bypassing formal FDA review.

While the administration has taken a decisive step toward closing what Kennedy has frequently termed a "food safety loophole," the policy landscape remains complex. Simultaneously, the FDA has hit a significant roadblock in its promise to define "ultra-processed foods" (UPFs), a cornerstone of the administration’s "Make America Healthy Again" (MAHA) agenda.

The Evolution of the GRAS Rule: From 1958 to Today

To understand the magnitude of this proposal, one must look at the history of the GRAS designation. Created by Congress in 1958, the GRAS provision was originally intended to exempt common, long-established ingredients—like salt, vinegar, or baking soda—from the rigorous pre-market approval processes required for new food additives.

However, in 1972, the system underwent a transformation that critics argue compromised its integrity: the introduction of the "self-affirmation" pathway. Under this current regime, a company can convene a private panel of experts to conclude that a new substance is safe for consumption. Once this "self-determination" is made, the company is under no legal obligation to notify the FDA or disclose the safety data to the public.

This system, intended to streamline innovation, has become a massive point of contention. Industry proponents argue that it allows for agility and reduces bureaucratic drag. Critics, including Secretary Kennedy, argue that it has allowed thousands of substances—some with little to no publicly available safety data—to enter the American diet without the scrutiny of federal regulators.

Chronology of the Regulatory Pivot

The path to this current proposal has been marked by mounting public pressure and internal administrative debates:

• 1958: Congress passes the Food Additives Amendment, establishing the GRAS concept for ingredients commonly used prior to 1958.
• 1972: The FDA implements the self-affirmation provision, allowing companies to bypass agency review if their private expert panels deem an ingredient safe.
• 2021: A federal judge rules that while the FDA has the authority to maintain a voluntary review program, it does not explicitly have the power to force all industry players into a mandatory notification system without further regulatory action.
• 2025 (September): The administration first signals its intent to reform the GRAS system within the Unified Agenda of Federal Regulatory and Deregulatory Actions.
• 2026 (August 11): The official proposal is published in the Federal Register, marking the start of a 120-day public consultation period.

The Mechanics of the Proposed Rule

The FDA’s proposed rule is not an outright ban on self-determination, but rather a move toward mandatory transparency. Under the new guidelines, manufacturers would be required to submit a formal GRAS notice to the FDA for any substance intended for use in human food.

Crucially, the proposal does not strictly mandate a "pre-market review" in the sense that the FDA must approve every ingredient before it hits the shelf. Instead, it creates a mandatory notification system. If a company fails to file this notice, the FDA would flag the product for prioritized "post-market" scrutiny.

The "Grandfathering" of Existing Substances

The administration recognizes the massive logistical hurdle of reviewing the estimated 2,000+ self-affirmed substances currently on the market. To manage this, the proposal outlines a streamlined submission pathway. Companies will have one year to provide basic documentation—such as the name of the substance, conditions of use, and proof of prior commerce—without necessarily needing to submit a full, exhaustive safety dossier.

The FDA estimates this simplified process will take approximately 31.5 hours per submission, a fraction of the 180 hours required for a full safety review. However, the agency reserves the right to demand a deep-dive safety petition if the initial information raises red flags.

Official Responses and Legal Scrutiny

The reception to the proposal has been polarized, reflecting the tension between public health advocacy and commercial interests.

The Administration’s Stance

Acting FDA Commissioner Kyle Diamantas has framed the policy as a vital modernization effort. "By proposing mandatory GRAS notifications, we are closing critical information gaps and giving the FDA greater visibility into substances entering the food supply," Diamantas stated. The agency argues that this will foster greater consumer confidence and provide a much-needed check on the industry’s internal assessment panels.

The Industry Perspective

Legal experts and industry advocates have raised concerns regarding the agency’s legal authority. Ashish Talati, a specialist in FDA regulatory law, points to the lack of clear congressional backing for such a broad mandate. "The FDA has made an extensive case for why it wants the information," Talati noted. "I am less convinced that it has made the case for why Congress gave it the legal authority to require it."

Furthermore, there is the issue of resources. Industry consultants warn that if the FDA does not receive a commensurate increase in funding to handle the influx of mandatory notifications, the 180-day review timeline will collapse, leading to significant bottlenecks for food-tech innovators, particularly those in the precision fermentation and alternative protein sectors.

Implications for Food Technology and Innovation

The hardest hit by these changes will likely be the burgeoning food-tech sector. Companies utilizing synthetic biology, fermentation, and novel fats have frequently relied on the self-affirmed GRAS pathway to bring products to market quickly.

If these companies are suddenly required to navigate a mandatory notification process—even one that stops short of full pre-market approval—the cost of entry into the US market will rise. Investors are already bracing for a potential "chilling effect," where the increased risk of FDA intervention post-launch might deter retailers from stocking products that haven’t received a formal "no questions" letter from the regulator.

The UPF Bottleneck: Why Defining "Ultra-Processed" is So Difficult

While the GRAS reform represents a clear, albeit controversial, path forward, the administration’s attempt to define and regulate ultra-processed foods (UPFs) remains stuck in the mud.

UPFs—which now account for an estimated 55% of the average American’s caloric intake—are at the heart of the "Make America Healthy Again" campaign. Despite Secretary Kennedy’s aggressive rhetoric, which has included calling certain UPFs "poison," the FDA has admitted that creating a standard, legal definition is proving to be an Herculean task.

The Complexity of Categorization

The problem is one of nuance. If the FDA defines UPFs based on high processing, they risk stigmatizing nutritionally beneficial products like fortified plant-based milks or fiber-enriched bread alongside sugar-laden snacks and sodas.

"Defining UPFs is really hard," admitted Acting Deputy Commissioner Donald Prater. The agency is currently attempting to create a foundational definition that could guide future nutrition research, but they have provided no timeline for when this might be finalized or how it would translate into actual policy, such as labeling requirements.

Public Sentiment vs. Policy Reality

The disconnect between public demand and regulatory action is striking. With 72% of consumers actively trying to avoid UPFs and 79% viewing them as a "significant threat" to public health, there is intense political pressure for the administration to "do something." However, an outright ban or aggressive regulation appears to be off the table, with the government instead pivoting toward the idea of "non-ultra-processed" labeling—a strategy that mimics the "sugar-free" or "fat-free" trends of previous decades.

Looking Ahead: A More Transparent Future?

The publication of the GRAS proposal on August 11 will launch a 120-day public comment period that promises to be one of the most significant debates in the history of US food regulation.

If finalized, the mandate will transform the relationship between the FDA and the food industry, shifting the burden of proof from the regulator back to the manufacturer. While the move is a clear victory for transparency advocates, it leaves open fundamental questions about the limits of administrative power and the capacity of the FDA to manage an increasingly complex and technologically driven food supply.

For now, the industry waits. As the 120-day clock begins, companies are reviewing their portfolios to assess which of their "self-affirmed" ingredients might now require a more rigorous justification. Meanwhile, the wait for a definitive policy on ultra-processed foods continues, serving as a reminder that even in an era of sweeping reform, the hardest challenges in food policy are often the ones that defy simple definition.